Hiroaki Ishibashi

749 total citations
31 papers, 588 citations indexed

About

Hiroaki Ishibashi is a scholar working on Molecular Biology, Cancer Research and Otorhinolaryngology. According to data from OpenAlex, Hiroaki Ishibashi has authored 31 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Otorhinolaryngology. Recurrent topics in Hiroaki Ishibashi's work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Fibroblast Growth Factor Research (4 papers). Hiroaki Ishibashi is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Fibroblast Growth Factor Research (4 papers). Hiroaki Ishibashi collaborates with scholars based in Japan, Germany and Czechia. Hiroaki Ishibashi's co-authors include Kanemitsu Shirasuna, Katsuo Sueishi, Mitsuho Onimaru, Kazunori Nakagawa, Masuichiro OKA, Yasuharu TAKENOSHITA, Yoshikazu Yonemitsu, Joji Sekine, Yoshiki Nariai and Yutaka Nakashima and has published in prestigious journals such as Circulation Research, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Hiroaki Ishibashi

29 papers receiving 566 citations

Peers

Hiroaki Ishibashi
Comparison fields: 5 of 94
  • Molecular Biology 239
  • Surgery 113
  • Cancer Research 97
  • Oncology 84
  • Oral Surgery 73
Replace Yunong Wu with:
Yunong Wu China
Satoshi Rokutanda Japan
Naoya Izumi Japan
Mizuo Sugimoto Japan
Yoko Miwa Japan
Norifumi Moritani Japan
Aruna Khare United States
Yongchao Gou China
Tianqian Hui China
Stephen P. Henry United States
Yunong Wu China View profile →
Citations per field, relative to Hiroaki Ishibashi
Hiroaki Ishibashi · 1×
Citations per year, relative to Hiroaki Ishibashi
Hiroaki Ishibashi · 1×

Countries citing papers authored by Hiroaki Ishibashi

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ishibashi more than expected).

Fields of papers citing papers by Hiroaki Ishibashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ishibashi. The network helps show where Hiroaki Ishibashi may publish in the future.

Co-authorship network of co-authors of Hiroaki Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ishibashi. A scholar is included among the top collaborators of Hiroaki Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ishibashi. Hiroaki Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 17
2 26
3 6
4 18
5 1
6 30
7 3
8 1
9 8
10 2
11 40
12
1
13 27
14
0
15 44
16
Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities.
83
17 26
18 12
19 66
20 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026